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A 5-year-old female developed, after a 7-month period
of fever, anorexia, weight loss, and a transitory cuta-
neous erythematous eruption, a severe acute transverse
myelopathy, with a partial recovery of motor and
sensory function. She had positive antinuclear and
antidouble-stranded DNA antibodies but no antiphos-
pholipid antibodies. Six months later she had massive
proteinuria and restarted treatment with steroids and
cyclophosphamide. Our patient is one of the youngest
reported with lupus myelopathy. We discuss the clini-
cal presentation, the magnetic resonance imaging find-
ings, and other relevant laboratory studies of this rare
but serious complication of systemic lupus erythema-
tosus. © 2002 by Elsevier Science Inc. All rights
reserved.
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Introduction
Systemic lupus erythematosus is a systemic autoim-
mune disease with frequent neurologic complications. In
children the reported incidence of these complications
varies from 13% to 45% [1-3].
Brain organic syndrome, psychosis, headache, move-
ment disorders (chorea, ballismus, and ataxia), cranial and
peripheral neuropathies, and myelopathy are the described
neurologic manifestations of systemic lupus erythemato-
sus [1-3].
Myelopathy, first described in 1959, is a rare compli-
cation of systemic lupus erythematosus and is particularly
rare in children, with only 13 cases reported in patients
younger than 18 years of age, mostly occurring in adoles-
cents [1,4-7].
Lupus myelopathy appears to have a stereotyped pre-
sentation in children and adults that is emerging from the
published reports and includes variable time of onset of
the systemic disease, acute flaccid paralysis, inflammatory
cerebrospinal fluid profile with pleocytosis, raised protein
and depressed glucose values, usually (but not always)
positive antiphospholipid antibodies, extensive abnormal-
ity of spinal cord signal on magnetic resonance imaging,
and a variable prognosis for recovery.
Our patient is one of the youngest reported with lupus
myelopathy and has raised several questions regarding
diagnosis and treatment.
Case Report
Our patient is a 5-year-old female, the only child of healthy, noncon-
sanguineous parents. She had no relevant family history, perinatal
problems, or past diseases and had a normal psychomotor development.
Seven months before admission she began complaining of pain in the
right lower limb, especially in the knee. Anorexia and weight loss were
also present. Three months later she was presented for surgical interven-
tion for an acute appendicitis with appendicular abscess. After surgery
she suffered a prolonged intermittent febrile syndrome, lower limb pain,
and a transitory diffuse erythematous rash. Three days before admission,
she had a high fever, and lower limb pain worsened. Antibiotic therapy
was begun while waiting for culture results for presumed urinary tract
infection. She was brought to the emergency department after the acute
(within a few hours) emergence of flaccid paraplegia, para-anesthesia
with a D10 level, and urinary retention.
She was admitted to the intensive care unit. During the next 24-48
hours her clinical condition worsened. She became tetraplegic and
required ventilatory support. General examination revealed no abnormal-
ities except for the fever, questionable nuchal rigidity, and slight
dehydration. Her blood pressure was normal, no cutaneous abnormalities
were apparent, and liver and spleen were not enlarged.
The child was alert and cooperative with normal mental function.
Cranial nerve examination was normal. She could make movements of
flexion and extension of the neck, shoulder abduction, and forearm
flexion in the left upper limb, but no other movements were possible.
Muscle tone was globally reduced, and reflexes were abolished except
for the biceps and radial reflexes on the left side. Anesthesia, tactile, algic
and thermal, was apparent up to the levels C3 on the right and C8-D1 on
the left. Proprioceptive sensation was difficult to evaluate although some
preservation could be present.
The spinal cord magnetic resonance imaging revealed extensive
multifocal areas of hypersignal in the T1- and T2-weighted sequences
from the C2-C3 level down to the conus medullaris (Fig 1). Brain
magnetic resonance imaging was normal. The most important laboratory
findings are summarized in Table 1.
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The patient was initially treated with ceftriaxone, vancomycin, and
dexamethasone. Therapy was changed after 3 weeks to pulses of
methylprednisolone and cyclophosphamide. Assisted ventilation was
maintained for 25 days. The patient recovered normal motor and sensory
function in the upper limbs, although a flaccid paraplegia and para-
anesthesia remained at the D10 level. There was some preservation of
proprioceptive sensation in the lower limbs bilaterally. She sometimes
complained of abnormal sensations in the lower limbs and referred to the
feeling of bladder repletion, although the pattern of bladder function
reflects a probable sphincter-detrusor dyssynergia.
Spinal cord magnetic resonance imaging 12 months later revealed the
disappearance of the cervical and upper dorsal cord hypersignal, but from
the D6 level and lower the cord is severely atrophic, which is more
evident at the D9 to D11 level that previously demonstrated contrast
enhancement (Fig 2).
Six months after the myelopathy the patient developed massive
proteinuria, which required the reinstitution of steroid and cyclophosph-
amide treatment. Renal biopsy revealed lesions of focal and segmental
proliferative glomerulonephritis.
Discussion
We consider that our patient’s disease is systemic lupus
erythematosus complicated with myelopathy, although we
initially suggested the alternative diagnosis of an infec-
tious or para-infectious myelopathy. A prolonged febrile
disease with a rash and limb pain could be caused by
several viral infections, including Epstein-Barr virus and
Cytomegalovirus [8,9]. These agents are well-known
causes of a transverse myelopathy, as well as enterovirus
(coxsackievirus and ECHO virus), mumps, herpes simplex
and varicella-zoster viruses, Mycoplasma pneumoniae
and, Borrelia burgdorferi [8,9]. The results of the sero-
logic studies were not compatible with these infections,
however, and the positive antinuclear and anti-DNA anti-
bodies favored the diagnosis of systemic lupus erythema-
tosus. The late development of a massive proteinuria and
glomerulonephritis are further arguments for the diagnosis
of systemic lupus erythematosus as are the persistently
positive ANA, anti-dsDNA, and depressed C3 and C4
serum levels.
Figure 1. Cervical cord T2-weighted magnetic resonance imaging (TR
 4,000 ms, TE  105 ms) demonstrates edema and hyperintense
abnormal signal.
Table 1. Laboratory findings in the acute phase and 2 weeks and 6 months later
Initial Fifteenth Day 6 Months
ESR 100 mm/hr ESR 62 mm/hr
CMV, EBV, herpesviruses, enteroviruses, Mycoplasma pneumoniae,
Borrelia burgdorferii, negative bacterial cultures (blood and CSF)
negative
CSF bacterial culture negative
ANA 1/160, homogeneous pattern ANA 1/160, homogeneous pattern
Anti-dsDNA  50 IU/mL Anti-dsDNA  50 IU/mL
C3, C4 normal C3 0.677 g/L (N:1.11–1.71)
APLAs negative C4 0.089 g/L (N:0.1–0.34)
ACLAs negative
CSF: 600 cells/mm3, PMN CSF: 32 cells/mm3, lymphocytes
261 mg/dL protein 167 mg/dL protein
43 mg/dL glucose 30 mg/dL glucose
Proteinuria 0 Proteinuria 30 mg/M2/hr
Abbreviations:
ACLA  Anticardiolipin antibodies
ANA  Antinuclear antibodies
Anti-dsDNA  Antidouble-stranded DNA antibodies
APLA  Antiphospholipid antibodies
CMV  Cytomegalovirus
CSF  Cerebrospinal fluid
EBV  Epstein-Barr virus
ESR  Erythrocyte sedimentation rate
PMN  Polymorphonuclear leukocytes
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Neurologic complications of systemic lupus erythema-
tosus were reported in 24-51% of adults and in 13-45% of
children [1-3].
Acute transverse myelitis is a rare but well-recognized
complication (less than 1% of all cases of lupus; only 13
cases reported in children) [4-7]. The youngest child with
systemic lupus erythematosus and myelopathy was 2 years
of age at the onset of symptoms [7].
The reported cases include several patients with early
onset or even as the initial manifestation of systemic lupus
erythematosus [10,11]. Most patients presented with acute
paraplegia, para-anesthesia, and sphincter dysfunction.
The prognosis for recovery is usually guarded and may be
related to prompt institution of steroid and cyclophospha-
mide therapy [10,11].
Many patients have antiphospholipid antibodies, and
myelopathy is believed to result (in some cases) from a
thrombotic vasculopathy with fibrinoid necrosis of small
vessels in the spinal cord. Nomura et al. [12] reported one
14-year-old patient with acute transverse myelitis, an-
tiphospholipid antibodies, and no clinical or laboratory
evidence of systemic lupus erythematosus. Magnetic res-
onance imaging in this patient revealed an extensive cord
lesion that did not have a vascular pattern [12].
The few reported cases with pathologic examination
[13,14] reveal different types of lesions and perhaps
different pathogenetic mechanisms. Some postmortem
examinations revealed prominent vascular lesions (fibrin-
oid necrosis of arterioles and venules and perivascular
lymphocytic infiltration) and myelomalacia, whereas oth-
ers had surprisingly few or no vascular lesions and
revealed an extensive demyelination and axonal and glial
loss [13,14].
Magnetic resonance imaging in most cases revealed an
extensive area of abnormal signal in the thoracic, lumbar,
and sacral cord [5-7,10,15,16]. The reversibility of this
abnormal signal would be more consistent with the hy-
pothesis of demyelination, especially when a clinical
recovery and resolution of the imaging abnormalities are
observed.
Cerebrospinal fluid findings that demonstrate an active
inflammatory process with prominent pleocytosis, raised
protein levels, and depressed glucose levels also would be
unlikely with a purely vascular thrombotic occlusion.
Our patient demonstrates all the above-mentioned fea-
tures, including acute onset, extensive cord involve-
ment, partial recovery, and inflammatory cerebrospinal
fluid profile, although antiphospholipid antibodies were
absent.
The authors would like to thank Dr. Darryl deVivo for seeing this patient
and for his helpful suggestions and comments.
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